Agentic AI in Health Care: Regulatory Uncertainty, Federal Preemption, and Governance Strategies

Agentic AI in Health Care: Regulatory Uncertainty, Federal Preemption, and Governance Strategies

From AHLA's Speaking of Health Law by American Health Law Association

April 28, 2026 · 43 min

About this episode

The episode discusses the emergence of agentic AI in health care and the associated legal and regulatory challenges.

Andrew Mahler, Vice President of Privacy and Compliance Services, Clearwater, speaks with David Peloquin, Partner, Ropes & Gray LLP, about the emergence of agentic artificial intelligence (AI) in the health care industry and the accompanying legal and regulatory challenges. They discuss how agentic AI differs from earlier forms of AI, why this difference is legally meaningful in health care, some of the significant use cases that are being observed, the state legal and regulatory landscap...

People in this episode

Host: Andrew Mahler

Guest: David Peloquin

Topics covered

  • agentic AI
  • health care
  • regulatory challenges
  • legal implications
  • privacy
  • compliance

Keywords

  • agentic AI
  • health care
  • regulatory uncertainty
  • federal preemption
  • governance strategies
  • privacy
  • compliance

Mentioned in this episode

Organizations: Clearwater, Ropes & Gray LLP

More episodes of AHLA's Speaking of Health Law

Explore listener stats, chart rankings, contacts and more on the AHLA's Speaking of Health Law podcast page.